Month: March 2021

Schizophrenia, a chronic, neurological brain disorder, affects millions of people around the world. It causes a fracture between a person’s thoughts, feelings and behavior.

Phase II results appear promising for a new combination treatment for schizophrenia. Findings from previous studies have shown that the muscarinic receptor agonist xanomeline could be used as a novel...